J. Whitaker

Chief Tech/Sci/R&D Officer at OMEROS CORPORATION

68 year

Health Technology

Consumer Services

Profile

J.
Steven Whitaker is currently the Vice President-Clinical Development at Omeros Corp.
He previously worked as the Divisional Vice President at ICOS Corp from 1994 to 2007 and as the Chief Medical Officer & VP-Clinical Development at Allon Therapeutics, Inc. from 2008 to 2010.
Whitaker holds a graduate degree from the University of Washington, an undergraduate degree from Butler University, and a doctorate degree from The Indiana University School of Medicine.

J. Whitaker active positions

Companies	Position	Start
OMEROS CORPORATION	Chief Tech/Sci/R&D Officer	2019-10-31

All active positions of J. Whitaker

Former positions of J. Whitaker

Companies	Position	End
ALLON THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	2010-02-28
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Corporate Officer/Principal	2007-04-30

See the detail of J. Whitaker's experience

Training of J. Whitaker

University of Washington	Graduate Degree
Butler University	Undergraduate Degree
The Indiana University School of Medicine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of J. Whitaker's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
OMEROS CORPORATION	Health Technology
ALLON THERAPEUTICS INC.	Health Technology

Private companies	1
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Health Technology